Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 3
This trial is looking at 2 new drugs called trastuzumab emtansine (TDM1) and pertuzumab for breast cancer that has spread to another part of the body (secondary breast cancer) or has come back in the same area (local recurrence). It is for people who have breast cancer that is HER2 positive.
Recruitment start: 1 November 2010
Recruitment end: 29 February 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Coleman
Experimental Cancer Medicine Centre (ECMC)
Genentech Ltd
NIHR Clinical Research Network: Cancer
Roche
Last reviewed: 04 Aug 2016
CRUK internal database number: 6817
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
